MedlinePlus Medical Encyclopedia: Macroglobulinemia of Waldenstrom

Skip navigation


Medical Encyclopedia
Other encyclopedia topics:	A-Ag Ah-Ap Aq-Az B-Bk Bl-Bz C-Cg Ch-Co Cp-Cz D-Di Dj-Dz E-Ep Eq-Ez F G H-Hf Hg-Hz I-In Io-Iz J K L-Ln Lo-Lz M-Mf Mg-Mz N O P-Pl Pm-Pz Q R S-Sh Si-Sp Sq-Sz T-Tn To-Tz U V W X Y Z 0-9

Macroglobulinemia of Waldenstrom

Contents of this page:
Illustrations Alternative names Definition Causes, incidence, and risk factors Symptoms	Signs and tests Treatment Expectations (prognosis) Complications Calling your health care provider

Illustrations

Waldenstroms

Antibodies

Alternative names Return to top

Waldenstrom's macroglobulinemia; Macroglobulinemia - primary

Definition Return to top

Macroglobulinemia of Waldenstrom is a cancer of the B lymphocytes (a type of white blood cell) that causes overproduction of monoclonal macroglobulin (IgM antibody).

Causes, incidence, and risk factors Return to top

The cause of this disease is unknown. It is characterized by overproduction of IgM, which causes the blood to become too thick (hyperviscosity).

This hyperviscosity interferes with blood flow through small blood vessels, which leads to many of the symptoms of the disease. The disease occurs in 5 out of 100,000 people over 50 years old.

Symptoms Return to top

Fatigue
Easy bruising of the skin
Rash
Nosebleeds (epistaxis)
Bleeding of the gums
Unintentional weight loss
Vision loss in one eye
Headache
Dizziness
Blurred or decreased vision
Mental status changes
Peripheral neuropathy (changes in the nerves affecting the hands, feet, fingers, toes, ears, or nose) manifested by:
- Numbness or tingling
- Burning pain

Additional symptoms that may be associated with this disease:

Signs and tests Return to top

A physical examination may reveal enlarged spleen, liver, and lymph nodes. A retinal eye examination (examination of the eye with an ophthalmoscope) may reveal enlarged (engorged) retinal veins or retinal bleeding (hemorrhages).

A CBC shows low red blood cell count and platelet count.
Serum protein electrophoresis shows a monoclonal spike (increased amount of a monoclonal protein). This may be seen as a serum immunoelectrophoresis that shows an IgM spike or a serum immunofixation that shows an IgM spike.
Urine immunoelectrophoresis shows IgM or a urine test for urine Bence-Jones proteins (quantitative) may be positive.

Bone lesions are very rare. If they are present, a bone marrow examination will show cells that resemble both lymphocytes and plasma cells. A blood chemistry shows evidence of renal disease (kidney disease).

This disease may also alter the results of the following tests:

Treatment Return to top

Apheresis (in this case, it is called plasmapheresis or plasma exchange) is a procedure for removing unwanted substances from the blood. In macroglobulinemia, it is used to control the symptoms caused by hyperviscosity by removing or reducing the high concentration of IgM.

Blood is withdrawn from the person in the same way as for a blood donation, and the blood is passed through a cell separator that removes the plasma (the fluid portion, which contains the antibodies).

The formed elements (blood cells) are reconstituted with a plasma substitute or with donated plasma. The reconstituted blood is then returned to the body in a blood transfusion. This is an acute procedure designed to quickly control symptoms.

Drug therapy may include Leukeran, Alkeran, Cytoxan, or corticosteroids.

Anemia (deficient number of red blood cells), leukopenia (deficient number of white blood cells) and thrombocytopenia (deficient number of platelets) in the later stages of the disease may require the use of packed red cell transfusions, antibiotics, or platelet transfusions.

Expectations (prognosis) Return to top

The median (average) survival is about 5 years. In some people, the disorder may be chronic with few symptoms and slow progression.

Complications Return to top

Vision impairment
Gastrointestinal bleeding
Alterations in mental status possibly progressing to coma
Congestive heart failure

Calling your health care provider Return to top

Call your health care provider if symptoms of this disorder develop.

Update Date: 8/3/2004

Updated by: Marcia S. Brose, M.D., Ph.D., Assistant Professor, Hematology/Oncology, The University of Pennsylvania Cancer Center, Philadelphia, PA. Review provided by VeriMed Healthcare Network.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2002 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.